Efficacy and Safety of Peroral Endoscopic Myotomy in Achalasia Patients with Failed Previous Intervention: A Systematic Review and Meta-Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Peroral endoscopic myotomy (POEM) has emerged as a rescue treatment for recurrent or persistent achalasia after failed initial management. Therefore, we aimed to investigate the efficacy and safety of POEM in achalasia patients with failed previous intervention. We searched the MEDLINE, Embase, Cochrane, and PubMed databases using the queries “achalasia,” “peroral endoscopic myotomy,” and related terms in March 2019. Data on technical and clinical success, adverse events, Eckardt score and lower esophageal sphincter (LES) pressure were collected. The pooled event rates, mean differences (MDs) and risk ratios (RR) were calculated. A total of 15 studies with 2,276 achalasia patients were included. Overall, the pooled technical success, clinical success and adverse events rate of rescue POEM were 98.0% (95% confidence interval [CI], 96.6% to 98.8%), 90.8% (95% CI, 88.8% to 92.4%) and 10.3% (95% CI, 6.6% to 15.8%), respectively. Seven studies compared the clinical outcomes of POEM between previous failed treatment and the treatment naïve patients. The RR for technical success, clinical success, and adverse events were 1.00 (95% CI, 0.98 to 1.01), 0.98 (95% CI, 0.92 to 1.04), and 1.17 (95% CI, 0.78 to 1.76), respectively. Overall, there was significant reduction in the pre- and post-Eckardt score (MD, 5.77; p<0.001) and LES pressure (MD, 18.3 mm Hg; p<0.001) for achalasia patients with failed previous intervention after POEM. POEM appears to be a safe, effective and feasible treatment for individuals who have undergone previous failed intervention. It has similar outcomes in previously treated and treatment-naïve achalasia patients.
Abstract
Peroral endoscopic myotomy (POEM) has emerged as a rescue treatment for recurrent or persistent achalasia after failed initial management. Therefore, we aimed to investigate the efficacy and safety of POEM in achalasia patients with failed previous intervention. We searched the MEDLINE, Embase, Cochrane, and PubMed databases using the queries “achalasia,” “peroral endoscopic myotomy,” and related terms in March 2019. Data on technical and clinical success, adverse events, Eckardt score and lower esophageal sphincter (LES) pressure were collected. The pooled event rates, mean differences (MDs) and risk ratios (RR) were calculated. A total of 15 studies with 2,276 achalasia patients were included. Overall, the pooled technical success, clinical success and adverse events rate of rescue POEM were 98.0% (95% confidence interval [CI], 96.6% to 98.8%), 90.8% (95% CI, 88.8% to 92.4%) and 10.3% (95% CI, 6.6% to 15.8%), respectively. Seven studies compared the clinical outcomes of POEM between previous failed treatment and the treatment naïve patients. The RR for technical success, clinical success, and adverse events were 1.00 (95% CI, 0.98 to 1.01), 0.98 (95% CI, 0.92 to 1.04), and 1.17 (95% CI, 0.78 to 1.76), respectively. Overall, there was significant reduction in the pre- and post-Eckardt score (MD, 5.77; p<0.001) and LES pressure (MD, 18.3 mm Hg; p<0.001) for achalasia patients with failed previous intervention after POEM. POEM appears to be a safe, effective and feasible treatment for individuals who have undergone previous failed intervention. It has similar outcomes in previously treated and treatment-naïve achalasia patients.
참고문헌 (34)
- Boeckxstaens GE, "The lower oesophageal sphincter", Neurogastroenterol Motil, 17(Suppl 1), pp.13~21 (2005)
- Moonen A, "Long-term results of the European achalasia trial : a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy", Gut, 65, pp.732~739 (2016)
- Boeckxstaens GE, "Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia", N Engl J Med, 364, pp.1807~1816 (2011)
- Emami MH, "Pneumatic balloon dilation therapy is as effective as esophagomyotomy for achalasia", Dysphagia, 23, pp.155~160 (2008)
- Kumbhari V, "Efficacy and safety of pneumatic dilatation for achalasia in the treatment of post-myotomy symptom relapse", Am J Gastroenterol, 108, pp.1076~1081 (2013)
- Borges AA, "Pneumatic dilation versus laparoscopic Heller myotomy for the treatment of achalasia : variables related to a good response", Dis Esophagus, 27, pp.18~23 (2014)
- Gutschow CA, "Botox, dilation, or myotomy? Clinical outcome of interventional and surgical therapies for achalasia", Langenbecks Arch Surg, 395, pp.1093~1099 (2010)
- Wang L, "Recurrent achalasia treated with Heller myotomy : a review of the literature", World J Gastroenterol, 14, pp.7122~7126 (2008)
- Horgan S, "Does botulinum toxin injection make esophagomyotomy a more difficult operation?", Surg Endosc, 13, pp.576~579 (1999)
- Deb S, "Laparoscopic esophageal myotomy for achalasia : factors affecting functional results", Ann Thorac Surg, 80, pp.1191~1194 (2005)
- Smith CD, "Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone", Ann Surg, 243, pp.579~584 (2006)
- Iqbal A, "Laparoscopic re-operation for failed Heller myotomy", Dis Esophagus, 19, pp.193~199 (2006)
- Legros L, "Long-term results of pneumatic dilatation for relapsing symptoms of achalasia after Heller myotomy", Neurogastroenterol Motil, 26, pp.1248~1255 (2014)
- Rakita S, "Outcomes promote reoperative Heller myotomy for symptoms of achalasia", Surg Endosc, 21, pp.1709~1714 (2007)
- Gockel I, "Heller myotomy for failed pneumatic dilation in achalasia: how effective is it?", Ann Surg, 239, pp.371~377 (2004)
- Tyberg A, "A multicenter international registry of redo per-oral endoscopic myotomy(POEM)after failed POEM", Gastrointest Endosc, 85, pp.1208~1211 (2017)
- Ling T, "Effect of peroral endoscopic myotomy in achalasia patients with failure of prior pneumatic dilation : a prospective case-control study", J Gastroenterol Hepatol, 29, pp.1609~1613 (2014)
- Ngamruengphong S, "Efficacy and safety of peroral endoscopic myotomy for treatment of achalasia after failed Heller myotomy", Clin Gastroenterol Hepatol, 15, pp.1531~1537 (2017)
- Tang X, "Feasibility and safety of peroral endoscopic myotomy for achalasia after failed endoscopic interventions", Dis Esophagus, 30, pp.1~6 (2017)
- Kristensen HØ, "Long-term outcome of peroral endoscopic myotomy for esophageal achalasia in patients with previous Heller myotomy", Surg Endosc, 31, pp.2596~2601 (2017)
- Tyberg A, "Peroral endoscopic myotomy as salvation technique post-Heller : international experience", Dig Endosc, 30, pp.52~56 (2018)
- Zhang X, "Per-oral endoscopic myotomy in patients with or without prior Heller’s myotomy : comparing long-term outcomes in a large U. S. single-center cohort(with videos)", Gastrointest Endosc, 87, pp.972~985 (2018)
- Orenstein SB, "Peroral endoscopic myotomy(POEM)leads to similarresults in patients with and without prior endoscopic or surgical therapy", Surg Endosc, 29, pp.1064~1070 (2015)
- Nabi Z, "Peroral endoscopic myotomy in treatment-naïve achalasia patients versus prior treatment failure cases", Endoscopy, 50, pp.358~370 (2018)
- Onimaru M, "Peroral endoscopic myotomy is a viable option for failed surgical esophagocardiomyotomy instead of redo surgical Heller myotomy : a single center prospective study", J Am Coll Surg, 217, pp.598~605 (2013)
- Vigneswaran Y, "Peroral endoscopic myotomy(POEM) : feasible as reoperation following Heller myotomy", J Gastrointest Surg, 18, pp.1071~1076 (2014)
- Sharata A, "Peroral endoscopic myotomy(POEM)is safe and effective in the setting of prior endoscopic intervention", J Gastrointest Surg, 17, pp.1188~1192 (2013)
- Zhou PH, "Peroral endoscopic remyotomy for failed Heller myotomy : a prospective single-center study", Endoscopy, 45, pp.161~166 (2013)
- Jones EL, "Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia", Surg Endosc, 30, pp.1282~1286 (2016)
- Liu ZQ, "The effect of prior treatment on clinical outcomes in patients with achalasia undergoing peroral endoscopic myotomy", Endoscopy, 51, pp.307~316 (2019)
- Moher D, "Preferred reporting items for systematic reviews and metaanalyses : the PRISMA statement", Int J Surg, 8, pp.336~341 (2010)
- Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", Eur J Epidemiol, 25, pp.603~605 (2010)
- Wells GA, "The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis" (2014), Ottawa Hospital Research Institute
- NOSCAR POEM White Paper Committee, "Per-oral endoscopic myotomy white paper summary", Gastrointest Endosc, 80, pp.1~15 (2014)